Global Polymerase Chain Reaction (PCR) Market Report 2024

The polymerase chain reaction (PCR) market size has grown rapidly in recent years. It will grow from $10.33 billion in 2023 to $11.42 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth observed during the historic period can be attributed to several factors, including the rising number of research facilities, the increasing number of patients with chronic and infectious diseases, the growing prevalence of genetic and chronic disorders, an expanding population, and a growing geriatric population.

The polymerase chain reaction (PCR) market size is expected to see rapid growth in the next few years. It will grow to $17.17 billion in 2028 at a compound annual growth rate (CAGR) of 10.7%. The anticipated growth in the forecast period can be attributed to rising concerns over food safety, increasing demand for safe and high-quality food products, and the growing demand for molecular diagnostics and personalized medicine, with a focus on digital polymerase chain reaction (dPCR). Key trends expected during this period include advancements in real-time polymerase chain reaction, DNA sequencing technologies, diagnostic testing, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and the development of advanced molecular diagnostic solutions.

The rising demand for personalized medicine is anticipated to drive the growth of the polymerase chain reaction (PCR) market. Personalized medicine, also known as precision medicine, involves tailoring healthcare decisions, practices, interventions, and treatments to the individual characteristics of each patient. The demand for personalized medicine is increasing due to advancements in data analytics, patient-specific treatment responses, and the ability to customize therapies based on individual genetic profiles. PCR plays a crucial role in personalized medicine by enabling the amplification and analysis of specific genetic sequences, allowing clinicians to create tailored treatment plans. For instance, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the approval of 12 new personalized medicines accounted for approximately 34% of all newly approved therapies, indicating a significant increase from previous years. Thus, the growing demand for personalized medicine is fueling the growth of the PCR market.

Leading companies in the PCR market are developing real-time polymerase chain reaction (RT-PCR) test kits to improve the accuracy, efficiency, and ease of use in genetic analysis. RT-PCR is a laboratory-developed test that amplifies and quantifies specific DNA sequences in real time. For example, in November 2022, Cepheid, a US-based molecular diagnostics company, launched the Xpert Xpress Multiplex Vaginal Panel (MVP), an FDA-cleared multiplex PCR test that detects DNA from organisms associated with three distinct vaginal infections - bacterial vaginosis (BV), vulvovaginal candidiasis, and trichomoniasis - from a single vaginal swab sample. This test enhances traditional PCR methods by providing real-time monitoring, quantification, and increased sensitivity and specificity, making it a crucial tool in molecular biology and clinical diagnostics.

In February 2021, Thermo Fisher Scientific Inc., a US-based biotechnology and laboratory equipment company, acquired Mesa Biotech for approximately $450 million. This acquisition enhances Thermo Fisher's PCR capabilities, expanding its portfolio with rapid point-of-care testing solutions for infectious diseases, including COVID-19, and strengthening its position in the molecular diagnostics market. Mesa Biotech Inc., a US-based molecular diagnostic company, develops, manufactures, and commercializes molecular diagnostic tests using PCR technology.

Major companies operating in the polymerase chain reaction (PCR) market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co., Ambry Genetics Corporation, Biocartis SA, Centogene N.V., Veritas Genetics.

North America was the largest region in the polymerase chain reaction (PCR) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (PCR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the polymerase chain reaction (PCR) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Polymerase chain reaction (PCR) is a laboratory technique employed to amplify specific segments of DNA. This process involves repeated cycles of heating and cooling to denature, anneal, and extend DNA strands, leading to the exponential amplification of the target sequence.

The main types of PCR are conventional polymerase chain reaction and other variants. Conventional PCR is used to amplify a specific DNA segment through repeated heating and cooling cycles. It is utilized in diagnosing various conditions such as infectious diseases, oncology, and genetic disorders. Its applications span both medical and non-medical fields, including hospitals and clinics, pharmaceutical and biotechnology industries, diagnostic centers, and academic and research organizations.

The polymerase chain reaction (PCR) market research report is one of a series of new reports that provides polymerase chain reaction (PCR) market statistics, including polymerase chain reaction (PCR) industry global market size, regional shares, competitors with a polymerase chain reaction (PCR) market share, detailed polymerase chain reaction (PCR) market segments, market trends and opportunities, and any further data you may need to thrive in the polymerase chain reaction (PCR) industry. This polymerase chain reaction (PCR) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The polymerase chain reaction (PCR) market consists of revenues earned by entities by providing services such as DNA amplification, gene expression analysis, pathogen detection, viral load quantification, reverse transcriptase enzyme, custom assay development, clinical diagnostics, gene cloning, genotyping and mutation detection, pathogen detection, technical support, training, and troubleshooting assistance to researchers and laboratory professionals using their products. The market value includes the value of related goods sold by the service provider or included within the service offering. The polymerase chain reaction (PCR) market also includes sales of thermal cyclers, quantitative polymerase chain reaction (qPCR) instruments, digital polymerase chain reaction systems, reverse transcription polymerase chain reaction (RT-PCR) kits, reagents and consumables, master mixes, nucleotides, centrifuges, primers, pipettes, polymerase chain reaction plates and tubes, polymerase chain reaction cleanup and purification kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.